MMRF's CoMMpass Study Highlights and Moves Research of Myeloma Forward

“Patients did great” with a four-drug regimen for multiple myeloma, an expert told CURE®.

From FDA concerns to a potential new drug, CAR-T cell therapies were dominating oncology headlines last week.

For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown.

In this episode of the “Cancer Horizons” podcast, a physician assistant recalls his experience as a frontline health care worker during the COVID-19 pandemic and what it was like to get diagnosed with multiple myeloma during such a chaotic time.

I was diagnosed with myeloma more than two decades ago and am lucky to have support throughout.

Side effects from multiple myeloma, such as six inches of collapsed vertebrae, have made me adjust my lifestyle, but I make the most of what I can.